Before you sell to, join or invest in Kaida BioPharma Inc.
MentionFox check on Kaida BioPharma Inc.: only 2 sources on file so far (checked 7 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/kaida-biopharma-inc-form-d-26003028
Check Kaida BioPharma Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
Kaida BioPharma Inc. filed an amended Form D with the Securities and Exchange Commission on 2026-01-21.
Kaida BioPharma Inc. filed an amended Form D notice of an exempt securities offering with the SEC on January 21, 2026. The filing reports $1.60M sold. Its industry group is Biotechnology. It names Craig Pierson (President), Stella Vnook (Director), Richard Warburg (Director) (SEC Form D/A, January 21, 2026).
In its own words: “Seeking the first victory against ovarian cancer.” (kaida-biopharma.com, checked October 31, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Kaida BioPharma Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-01-21 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Kaida BioPharma Inc.
Free to see. No signup.
More on the people and the money behind Kaida BioPharma Inc., from the filings we hold.
Biotechnology raises by companies based in Florida, filed within 90 days of this one, largest first.
Get an email when Kaida BioPharma Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Kaida BioPharma Inc. raises, hires or launches. No email unless you switch it on.
Watch Kaida BioPharma Inc. →Get the full cited report on Kaida BioPharma Inc.
What the filing shows about Kaida BioPharma Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Kaida BioPharma Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Kaida BioPharma Inc.'s address as 416 Sw 1ST Avenue, Suite 101, Fort Lauderdale, FL 33301.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Kaida BioPharma Inc. →
Amended on 2026-09-01: the offering size changed from $3,000,000 to $4,100,507; the amount sold changed from $1,570,507 to $1,600,507; the number of investors changed from 42 to 44. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Kaida BioPharma Inc. is a registered filer with the SEC (CIK 1973954) and has filed since 2023-06-14. 3 filings are on record, the latest on 2026-09-01.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Kaida BioPharma Inc.'s Form D of 2026-01-21 names Craig Pierson, Stella Vnook and Richard Warburg as its officers, directors or promoters.
Its new offerings report $1.57M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 763 filings in Biotechnology, totalled by week. The dot is this raise, $1.60M, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer, Director.
Craig Pierson is named as President on the Form D that Kaida BioPharma Inc. filed with the SEC on 21 January 2026, one of 3 people that filing names.
Stella Vnook is named as Director on the Form D that Kaida BioPharma Inc. filed with the SEC on 21 January 2026, one of 3 people that filing names.
Richard Warburg is named as Director on the Form D that Kaida BioPharma Inc. filed with the SEC on 21 January 2026, one of 3 people that filing names.
3 people named on the filing — 1 holding an executive role and 2 as directors only.
Named as of the 2026-01-21 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Kaida BioPharma Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Kaida BioPharma Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Kaida BioPharma Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Kaida BioPharma Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Kaida BioPharma Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Kaida BioPharma Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Miami
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/kaida-biopharma-inc-form-d-26003028